跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

Ruboxistaurin

首页药物Ruboxistaurin

Investigational

Small Molecule

Ruboxistaurin

未知生产厂商

Ruboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus.

生成 AI 研报

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Ruboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus.

技术标识符

化学式: C₂₈H₂₈N₄O₃
CAS 编号: 169939-94-0
UNII ID: 721809WQCP

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

COMPOSITIONS AND FORMULATIONS FOR USE OF A PK INHIBITOR FOR THE PREVENTION, TREATMENT, AND IMPROVEMENT OF SKIN DISEASES, CONDITIONS, AND DISORDERS
EP 4525862 A4申请人: DERMBIONT INC优先权: 2022
EP
US
WO
7 件公开
POLYMORPHS OF N-DESMETHYL RUBOXISTAURIN AND SALTS THEREOF
EP 4698538 A1申请人: 4M THERAPEUTICS INC优先权: 2023
EP
US
WO
3 件公开
Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders
US 9265764 B2申请人: HAGGARTY STEPHEN J优先权: 2010
US
2 件公开
Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations
US 9562015 B2申请人: UNIV COLORADO REGENTS优先权: 2012
US
2 件公开
Methods For Diagnosing And Treating Diabetic Microvascular Complications
US 2008096923 A1申请人: GIRACH ANIZ优先权: 2005
US
Combination Therapy for Vascular Complications Associated with Hyperglycemia
US 2007281988 A1申请人: CAMERON NORMAN E优先权: 2005
US
Combination Methods for Preserving Visual Acuity
US 2008234351 A1申请人: SHEETZ MATTHEW JOHN优先权: 2006
US
Cicletanine and PKC inhibitors in the treatment of pulmonary and cardiac disorders
US 2008312241 A1申请人: GILEAD SCIENCES INC优先权: 2008
US
DEUTERIUM-ENRICHED RUBOXISTAURIN
US 2012136037 A1申请人: CZARNIK ANTHONY W优先权: 2008
US
Method of manufacturing ruboxistarin
EP 2181999 A1申请人: ZENTIVA KS优先权: 2008
EP

第 1 / 2 页